Back to news

Alcon Falls as Mixed Q3 Results and Tighter Outlook Pressure Shares

Investivoq PriceTracker

Alcon (ALC) is down 4.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to Alcon’s third-quarter update, which paired an earnings beat with softer revenue quality and a more cautious full-year outlook. Investors seem focused on weaker implantables demand, competitive pressure in premium intraocular lenses, and lower market growth assumptions rather than the headline profit figure.

Details:

  • Alcon reported third-quarter 2026 sales of $2.7 billion, up 5% year over year, with core diluted EPS of $0.91.
  • The company tightened its 2026 outlook to about 6% constant-currency sales growth, narrowed its core operating margin expansion range to 100 to 150 basis points, and trimmed the top end of its core EPS growth range to 12% to 14%.
  • Management said aggregate end markets are now expected to grow about 3% this year, and also flagged specific areas of competitive pressure.
  • Implantables sales fell 2% in the quarter, with weakness tied to the U.S. premium intraocular lens category and reimbursement pressure in certain procedures, which likely added to concerns about Alcon’s forward growth path.

    • Sources:

    Alcon Investor Relations, SEC, MarketScreener

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    Investivoq Alerts
    Receive ALC Data Alerts
    Get market-moving data, filings, and signals for ALC in real time.
    Sign Up

    $ALC Hedge Fund Activity

    We have seen 229 institutional investors add shares of $ALC stock to their portfolio, and 393 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • INVESCO LTD. added 10,020,691 shares (+2786.3%) to their portfolio in Q2 2026, for an estimated $672,388,366
    • FRANKLIN RESOURCES INC removed 3,464,603 shares (-80.7%) from their portfolio in Q2 2026, for an estimated $232,474,861
    • BANK OF NEW YORK MELLON CORP removed 2,921,037 shares (-22.4%) from their portfolio in Q3 2026, for an estimated $189,137,145
    • CANTILLON CAPITAL MANAGEMENT LLC removed 2,507,095 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $168,226,074
    • LBP AM SA added 2,414,092 shares (+inf%) to their portfolio in Q3 2026, for an estimated $156,312,457
    • JPMORGAN CHASE & CO added 2,221,073 shares (+inf%) to their portfolio in Q2 2026, for an estimated $149,033,998
    • TROY ASSET MANAGEMENT LTD removed 2,085,169 shares (-54.9%) from their portfolio in Q3 2026, for an estimated $135,014,692

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $ALC Congressional Stock Trading

    Members of Congress have traded $ALC stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

    Here’s a breakdown of recent trading of $ALC stock by members of Congress over the last 6 months:

    • REPRESENTATIVE KEVIN HERN sold up to $15,000 on 08/05.

    To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.